Kazuo Azuma Selected Research

Chitin

12/2020	Effects of surface-deacetylated chitin nanofibers on non-alcoholic steatohepatitis model rats and their gut microbiota.
1/2017	Oral Administration of Surface-Deacetylated Chitin Nanofibers and Chitosan Inhibit 5-Fluorouracil-Induced Intestinal Mucositis in Mice.
9/2016	Biomaterials based on freeze dried surface-deacetylated chitin nanofibers reinforced with sulfobutyl ether β-cyclodextrin gel in wound dressing applications.
1/2016	Chitin nanofibrils suppress skin inflammation in atopic dermatitis-like skin lesions in NC/Nga mice.
12/2015	Protective Effect of Chitin Urocanate Nanofibers against Ultraviolet Radiation.
7/2015	Effects of Surface-Deacetylated Chitin Nanofibers in an Experimental Model of Hypercholesterolemia.
6/2015	Favorable effects of superficially deacetylated chitin nanofibrils on the wound healing process.
1/2015	Anticancer and anti-inflammatory properties of chitin and chitosan oligosaccharides.
10/2014	Preparation and biomedical applications of chitin and chitosan nanofibers.
9/2012	α-Chitin nanofibrils improve inflammatory and fibrosis responses in inflammatory bowel disease mice model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuo Azuma Research Topics

Disease

23	Neoplasms (Cancer) 10/2020 - 10/2012
7	Inflammation (Inflammations) 03/2021 - 09/2014
4	Wounds and Injuries (Trauma) 03/2019 - 10/2014
3	Sarcoma (Soft Tissue Sarcoma) 06/2017 - 01/2014
3	Melanoma (Melanoma, Malignant) 01/2015 - 07/2013
2	Alcoholic Fatty Liver 03/2021 - 12/2020
2	Stroke (Strokes) 03/2021 - 12/2020
2	Burns 10/2020 - 01/2014
2	Hemorrhage 10/2020 - 06/2020
2	Breast Neoplasms (Breast Cancer) 01/2017 - 09/2016
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2015 - 09/2012
2	Neoplasm Metastasis (Metastasis) 01/2015 - 12/2012
2	Obesity 10/2014 - 02/2014
2	Hyperthermia 06/2014 - 01/2014
1	Chronic Renal Insufficiency 01/2022
1	Fatty Liver 03/2021
1	Mastitis 01/2021
1	Lymphoma (Lymphomas) 10/2020
1	Thrombosis (Thrombus) 06/2020
1	Snake Bites (Snake Bite) 06/2020
1	Corneal Diseases (Corneal Disease) 05/2020
1	Meningioma (Meningiomas) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Carcinoma (Carcinomatosis) 04/2019
1	Alopecia (Baldness) 04/2019
1	Hamartoma 07/2018
1	Type 2 Diabetes Mellitus (MODY) 07/2017
1	Lung Neoplasms (Lung Cancer) 07/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2017
1	Flushing 03/2017
1	Brain Neoplasms (Brain Tumor) 02/2017
1	Mucositis 01/2017

Drug/Important Bio-Agent (IBA)

10	ChitinIBA 12/2020 - 09/2012
5	Glucosamine (Dona)IBA 01/2015 - 08/2012
4	Indocyanine Green (Cardio-Green)FDA LinkGeneric 10/2020 - 01/2014
4	ChitosanIBA 04/2019 - 10/2014
4	Pharmaceutical PreparationsIBA 03/2019 - 10/2014
3	AcidsIBA 01/2020 - 04/2016
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2019 - 01/2017
3	Amino Acids FDA Link 02/2017 - 12/2012
3	AcetylglucosamineIBA 01/2015 - 08/2012
3	lupeolIBA 01/2015 - 07/2013
2	Polysaccharides (Glycans)IBA 01/2022 - 03/2021
2	sacranIBA 01/2022 - 03/2021
2	CholesterolIBA 12/2020 - 02/2014
2	protoporphyrin IXIBA 01/2020 - 04/2019
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018 - 04/2016
2	Biomarkers (Surrogate Marker)IBA 02/2017 - 12/2012
2	Biological ProductsIBA 09/2016 - 01/2015
2	OligosaccharidesIBA 01/2015 - 01/2015
2	TriterpenesIBA 01/2015 - 07/2013
2	Glucose (Dextrose)FDA LinkGeneric 02/2014 - 08/2012
1	LipidsIBA 03/2021
1	beta-lactamase CTX-2IBA 01/2021
1	FibrinIBA 06/2020
1	Monensin (Coban)IBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	EnzymesIBA 04/2019
1	Messenger RNA (mRNA)IBA 04/2019
1	Therapeutic UsesIBA 04/2019
1	Ferrochelatase (Heme Synthetase)IBA 04/2019
1	Dronabinol (THC)FDA LinkGeneric 03/2019
1	Excipients (Suspending Agents)IBA 03/2019
1	tetrahydrocurcuminIBA 03/2019
1	Cisplatin (Platino)FDA LinkGeneric 09/2018
1	TONS504IBA 08/2018
1	Liposomes (Liposome)IBA 01/2018
1	dioleoyl-N-(monomethoxypolyethylene glycol succinyl)phosphatidylethanolamineIBA 01/2018
1	GelatinIBA 11/2017
1	BiguanidesIBA 07/2017
1	Metformin (Glucophage)FDA LinkGeneric 07/2017
1	Talaporfin (talaporfin sodium)IBA 06/2017
1	ArtesunateIBA 03/2017
1	Proline (L-Proline)FDA Link 02/2017
1	Alanine (L-Alanine)FDA Link 02/2017
1	Isoleucine (L-Isoleucine)FDA Link 02/2017
1	Fluorouracil (Carac)FDA LinkGeneric 01/2017
1	ChromatinIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 09/2016
1	Ether (Diethyl Ether)IBA 09/2016
1	Biocompatible Materials (Biomaterials)IBA 09/2016
1	CyclodextrinsIBA 09/2016
1	GelsIBA 09/2016
1	Immunoglobulin E (IgE)IBA 01/2016

Therapy/Procedure

12	Therapeutics 10/2020 - 01/2014
6	Drug Therapy (Chemotherapy) 04/2019 - 01/2014
6	Oral Administration 01/2017 - 08/2012
2	Radiotherapy 10/2020 - 09/2018
2	Photochemotherapy (Photodynamic Therapy) 06/2017 - 01/2014
2	Injections 06/2014 - 07/2013
1	Nephrectomy 01/2022
1	Glossectomy 06/2020
1	Contact Lenses 05/2020
1	Aftercare (After-Treatment) 09/2018
1	Mandibular Osteotomy 07/2018
1	Intravenous Administration 01/2018
1	Lasers (Laser) 06/2017
1	Cholecystectomy 03/2017
1	Catheters 03/2017